FENNEC PHARMACEUTICALS INC. Public Float
FENNEC PHARMACEUTICALS INC. (FENC) had Public Float of $106.05 million as of 2025-06-30, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-27
- 2025-06-30: Entity Public Float $106.05M.
- 2024-06-30: Entity Public Float $82.18M.
- 2023-06-30: Entity Public Float $137.90M.
- 2022-06-30: Entity Public Float $98.21M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $106.05M 10-K · filed 2026-03-27 | |
| 2024-06-30 | $82.18M 10-K · filed 2025-03-26 | |
| 2023-06-30 | $137.90M 10-K · filed 2024-03-29 | |
| 2022-06-30 | $98.21M 10-K · filed 2023-03-29 | |
| 2021-06-30 | $97.83M 10-K · filed 2022-02-28 | |
| 2020-06-30 | $116.15M 10-K · filed 2021-03-30 | |
| 2019-06-30 | $45.97M 10-K · filed 2020-02-14 | |
| 2018-06-30 | $82.97M 10-K · filed 2019-03-15 | |
| 2017-06-30 | $45.27M 10-K · filed 2018-03-28 | |
| 2016-06-30 | $10.16M 10-K · filed 2017-03-29 | |
| 2015-06-30 | $15.22M 10-K · filed 2016-03-28 | |
| 2014-06-30 | $21.83M 10-K · filed 2015-03-31 | |
| 2013-06-30 | $2.80M 10-K · filed 2014-03-31 | |
| 2012-06-30 | $1.40M 10-K · filed 2013-04-01 | $6.73M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |